全文获取类型
收费全文 | 335713篇 |
免费 | 48704篇 |
国内免费 | 13532篇 |
专业分类
耳鼻咽喉 | 6822篇 |
儿科学 | 7930篇 |
妇产科学 | 5862篇 |
基础医学 | 23524篇 |
口腔科学 | 5177篇 |
临床医学 | 50270篇 |
内科学 | 75344篇 |
皮肤病学 | 9483篇 |
神经病学 | 24166篇 |
特种医学 | 12767篇 |
外国民族医学 | 74篇 |
外科学 | 59794篇 |
综合类 | 30198篇 |
现状与发展 | 102篇 |
一般理论 | 19篇 |
预防医学 | 20502篇 |
眼科学 | 8474篇 |
药学 | 20772篇 |
167篇 | |
中国医学 | 9702篇 |
肿瘤学 | 26800篇 |
出版年
2024年 | 1204篇 |
2023年 | 7215篇 |
2022年 | 7617篇 |
2021年 | 11502篇 |
2020年 | 12160篇 |
2019年 | 7701篇 |
2018年 | 13201篇 |
2017年 | 12700篇 |
2016年 | 13261篇 |
2015年 | 16281篇 |
2014年 | 25293篇 |
2013年 | 25197篇 |
2012年 | 19985篇 |
2011年 | 21219篇 |
2010年 | 20856篇 |
2009年 | 22556篇 |
2008年 | 16482篇 |
2007年 | 14852篇 |
2006年 | 16814篇 |
2005年 | 13597篇 |
2004年 | 9842篇 |
2003年 | 8294篇 |
2002年 | 7316篇 |
2001年 | 8186篇 |
2000年 | 7315篇 |
1999年 | 7357篇 |
1998年 | 5954篇 |
1997年 | 5642篇 |
1996年 | 5064篇 |
1995年 | 4820篇 |
1994年 | 3458篇 |
1993年 | 2436篇 |
1992年 | 2711篇 |
1991年 | 2612篇 |
1990年 | 2069篇 |
1989年 | 2039篇 |
1988年 | 1764篇 |
1987年 | 1521篇 |
1986年 | 1404篇 |
1985年 | 1105篇 |
1984年 | 789篇 |
1983年 | 739篇 |
1982年 | 645篇 |
1981年 | 521篇 |
1980年 | 439篇 |
1979年 | 465篇 |
1978年 | 441篇 |
1977年 | 482篇 |
1975年 | 329篇 |
1972年 | 389篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
Katie Mycock Lin Zhan Gavin Taylor-Stokes Gary Milligan Debanjali Mitra 《Current oncology (Toronto, Ont.)》2021,28(1):678
Background: Palbociclib is a selective cyclin-dependent kinase (CDK) 4/6 inhibitor used in combination with aromatase inhibitors or fulvestrant for patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2)-negative advanced/metastatic breast cancer (ABC/MBC). Palbociclib was the first CDK 4/6 inhibitor approved for HR+/HER2− ABC/MBC treatment in Canada in combination with letrozole (P+L) as an initial endocrine-based therapy (approved March 2016), or with fulvestrant (P+F) following disease progression after prior endocrine therapy (approved May 2017). The Ibrance Real World Insights (IRIS) study () collected real-world outcomes data for palbociclib-treated patients in several countries, including Canada. Methods: This retrospective chart review included women with HR+/HER2− ABC/MBC receiving P+L or P+F in Canada. Physicians reviewed medical records for up to 14 patients, abstracting demographic and clinical characteristics, treatment patterns, and clinical outcomes. Progression-free rates (PFRs) and survival rates (SRs) at 6, 12, 18, and 24 months were estimated via Kaplan–Meier analysis. Results: Thirty-three physicians examined medical records for 247 patients (P+L, n = 214; P+F, n = 33). Median follow-up was 8.8 months for P+L and 7.0 months for P+F. Most patients were initiated on palbociclib 125 mg/d (P+L, 90.2%; P+F, 84.8%). Doses were reduced in 16.6% of P+L and 14.3% of P+F patients initiating palbociclib at 125 mg/d. The PFR for P+L was 90.3% at 12 months and 78.2% at 18 months; corresponding SRs were 95.6% and 93.0%. For P+F, 6-month PFR was 91.0%; 12-month SR was 100.0%. Conclusions: Dose reduction rates were low and PFR and SR were high in this Canadian real-world assessment of P+L and P+F treatments, suggesting that palbociclib combinations are well tolerated and effective. NCT03159195相似文献
94.
95.
96.
A novel surgical technique to prevent post-enucleation conjunctival cyst:conjunctival staining with methylthioninium
下载免费PDF全文
![点击此处可从《国际眼科》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Dear Editor,Conjunctival cyst of the orbit acquired from enucleation is an infrequent but serious complication;which can occur in 3%-7%of patients,more commonly after a secondary procedure;.The most common manifestations are the inability to retain the external prosthesis. 相似文献
97.
98.
Marie V. Plaisime PhD MPH Marie Jipguep-Akhtar PhD Joseph J. Locascio PhD Harolyn M. E. Belcher MD MHS Rachel R. Hardeman PhD MPH Katherine Picho-Kiroga PhD Sylvia P. Perry PhD Sean M. Phelan PhD MPH Michelle van Ryn PhD LMFT MPH John F. Dovidio PhD 《Health services research》2023,58(Z2):229-237
Objective
To examine the experience of interracial anxiety among health professionals and how it may affect the quality of their interactions with patients from racially marginalized populations. We explored the influence of prior interracial exposure—specifically through childhood neighborhoods, college student bodies, and friend groups—on interracial anxiety among medical students and residents. We also examined whether levels of interracial anxiety change from medical school through residency.Data Source
Web-based longitudinal survey data from the Medical Student Cognitive Habits and Growth Evaluation Study.Study Design
We used a retrospective longitudinal design with four observations for each trainee. The study population consisted of non-Black US medical trainees surveyed in their 1st and 4th years of medical school and 2nd and 3rd years of residency. Mixed effects longitudinal models were used to assess predictors of interracial anxiety and assess changes in interracial anxiety scores over time.Principal Findings
In total, 3155 non-Black medical trainees were followed for 7 years. Seventy-eight percent grew up in predominantly White neighborhoods. Living in predominantly White neighborhoods and having less racially diverse friends were associated with higher levels of interracial anxiety among medical trainees. Trainees' interracial anxiety scores did not substantially change over time; interracial anxiety was highest in the 1st year of medical school, lowest in the 4th year, and increased slightly during residency.Conclusions
Neighborhood and friend group composition had independent effects on interracial anxiety, indicating that premedical racial socialization may affect medical trainees' preparedness to interact effectively with diverse patient populations. Additionally, the lack of substantial change in interracial anxiety throughout medical training suggests the importance of providing curricular tools and structure (e.g., instituting interracial cooperative learning activities) to foster the development of healthy interracial relationships. 相似文献99.
器官移植术是20世纪出现的针对器官功能衰竭的最有效治疗方法,每年拯救全球超过12万例患者。但供器官短缺的现状,与器官移植技术和辅助药物的发展不匹配,制约了器官移植事业的发展。我国自2015年起已成为全球器官捐献和移植大国之一,2017年公民逝世后器官捐献数量超过5 000例,占全球捐献总量的15%以上。黄洁夫教授总结的器官捐献与移植"中国模式"得到了世界卫生组织、国际移植界的高度重视和充分肯定。本文通过整理全球及各国的器官捐献与移植数据,剖析全球现状与发展趋势,进一步探索我国公民器官捐献的影响因素并提出针对性的应对策略,以期实现我国器官捐献和移植的"自给自足"。 相似文献
100.